Table 2.
Methodological Quality of the Included Studies
| Items | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total Score* |
| Barroso et al 34 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Bertani et al 21 | + | + | − | − | − | − | − | + | − | + | + | 4 |
| Blumenthal et al 22 | + | + | − | + | − | − | − | − | + | + | + | 5 |
| Blumenthal et al 23 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Brito et al 44 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Dimeo et al 30 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Farah et al 26 | + | + | + | + | − | − | + | − | − | + | + | 6 |
| Guimaraes et al 33 | + | + | − | + | − | − | + | − | − | + | + | 5 |
| Guimaraes et al 28 | + | + | + | − | − | + | − | − | + | + | 5 | |
| Lima et al 24 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Molmen‐Hansen et al 49 | + | + | − | + | − | − | − | − | − | + | + | 4 |
| Motlagh et al 20 | + | + | + | + | − | − | − | − | + | + | + | 6 |
| Pagonas et al 29 | + | + | − | + | − | − | − | + | − | + | + | 5 |
| Stiller‐Moldovan et al 32 | + | + | + | + | − | − | − | − | − | − | + | 4 |
| Westhoff et al 31 | + | + | − | − | − | − | − | + | − | + | + | 4 |
Column numbers correspond to the following criteria on the PEDro scale: (1) eligibility criteria were specified; (2) subjects were randomly allocated to groups; (3) allocation was concealed; (4) groups were similar at baseline; (5) subjects were blinded; (6) therapists who administered the treatment were blinded; (7) assessors were blinded; (8) measures of key outcomes were obtained from >85% of subjects; (9) data were analyzed by intention to treat; (10) statistical comparisons between groups were conducted; (11) point measures and measures of variability were provided.
*
Total score from item 2.